CymitQuimica logo

CAS 1041469-97-9

:

Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
  • RKS-262
    Targetmol
    + Info

    RKS-262

    CAS:
    RKS262, a cyclin/CDK blocker from optimized Nifurtimox, is in phase II trials for neuroblastoma and shows strong anti-cancer activity, especially in leukemia.
    Formula:C15H14BrClN2O4S
    Color and Shape:Solid
    Molecular weight:433.7

    Ref: TM-T71549

    25mg
    1,444.00€
    50mg
    1,882.00€
    100mg
    2,375.00€